Stockscreener 앱 받기
32.88
1.92%
0.62
전일 마감가:
$32.26
열려 있는:
$32.21
하루 거래량:
454.67K
Relative Volume:
0.77
시가총액:
$1.63B
수익:
$499.95M
순이익/손실:
$-36.36M
주가수익비율:
-42.70
EPS:
-0.77
순현금흐름:
$24.22M
1주 성능:
+3.40%
1개월 성능:
-15.82%
6개월 성능:
-8.26%
1년 성능:
-15.71%
1일 변동 폭
$32.00
$33.11
1주일 범위
$30.27
$33.72
52주 변동 폭
$28.29
$43.18
Atricure Inc Stock (ATRC) Company Profile
명칭
Atricure Inc
전화
513-755-4100
주소
7555 INNOVATION WAY, MASON, OH
Compare ATRC vs ISRG, BDX, ALC, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ATRC
Atricure Inc
|
32.88 | 1.60B | 499.95M | -36.36M | 24.22M | -0.77 |
|
ISRG
Intuitive Surgical Inc
|
498.08 | 177.84B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
182.45 | 51.97B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
82.78 | 40.42B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
MDLN
Medline Inc
|
47.41 | 39.70B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
RMD
Resmed Inc
|
256.41 | 37.72B | 5.40B | 1.49B | 1.78B | 10.12 |
Atricure Inc Stock (ATRC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-11 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-12-17 | 재개 | JP Morgan | Overweight |
| 2024-04-23 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2023-10-23 | 개시 | JMP Securities | Mkt Outperform |
| 2023-09-29 | 개시 | UBS | Buy |
| 2021-08-05 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-12-18 | 재확인 | Needham | Buy |
| 2020-11-06 | 재확인 | Needham | Buy |
| 2020-04-07 | 개시 | Oppenheimer | Outperform |
| 2020-02-06 | 개시 | BTIG Research | Buy |
| 2020-01-24 | 재확인 | Needham | Buy |
| 2019-08-13 | 다운그레이드 | Northland Capital | Outperform → Market Perform |
| 2019-04-12 | 개시 | JP Morgan | Overweight |
| 2018-10-04 | 재확인 | Needham | Buy |
| 2018-08-02 | 재확인 | Needham | Buy |
| 2018-08-02 | 재확인 | Stifel | Buy |
| 2018-06-18 | 재확인 | Needham | Buy |
| 2018-04-27 | 재확인 | Needham | Buy |
| 2018-01-16 | 재확인 | Needham | Buy |
| 2017-11-02 | 재확인 | Needham | Buy |
| 2017-07-28 | 재확인 | Needham | Buy |
| 2017-05-30 | 재개 | Piper Jaffray | Overweight |
| 2016-06-30 | 재개 | JMP Securities | Mkt Outperform |
| 2015-10-28 | 재확인 | Needham | Buy |
| 2015-10-06 | 재확인 | Canaccord Genuity | Buy |
| 2015-10-06 | 재확인 | Needham | Buy |
모두보기
Atricure Inc 주식(ATRC)의 최신 뉴스
AtriCure, Inc. SEC 10-K Report - TradingView
COR's MWI Animal Health to Merge With Covetrus in $3.5 Billion Deal - Finviz
AtriCure Earnings Call Highlights Growth Amid Headwinds - TipRanks
Demystifying AtriCure: Insights From 6 Analyst Reviews - Benzinga
ATRC: Canaccord Genuity Lowers Price Target, Maintains Buy Ratin - GuruFocus
Needham reiterates Buy on AtriCure stock, keeps $45 target - Investing.com UK
Needham reiterates Buy on AtriCure stock, keeps $45 target By Investing.com - Investing.com Nigeria
UBS Adjusts AtriCure Price Target to $55 From $60, Maintains Buy Rating - marketscreener.com
UBS Maintains 'Buy' Rating on AtriCure (ATRC), Lowers Price Targ - GuruFocus
Citizens Jmp Cuts AtriCure (NASDAQ:ATRC) Price Target to $52.00 - MarketBeat
AtriCure (ATRC) Analyst Maintains Rating, Lowers Price Target to $52 | ATRC Stock News - GuruFocus
AtriCure Delivers 15% Revenue Growth In FY25, Projects 12-14% Growth In FY26 - Nasdaq
This Masimo Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Benzinga
AtriCure, Inc. (NASDAQ:ATRC) Q4 2025 Earnings Call Transcript - Insider Monkey
AtriCure, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
BTIG Research Reaffirms "Buy" Rating for AtriCure (NASDAQ:ATRC) - MarketBeat
Oppenheimer downgrades AtriCure stock rating on competitive concerns - Investing.com UK
Canaccord Genuity lowers AtriCure stock price target on valuation By Investing.com - Investing.com Australia
AtriCure Q4 2025 revenue up 13.1% to USD 140.5M - Medical Buyer
ATRC Downgraded by Oppenheimer to 'Perform' | ATRC Stock News - GuruFocus
Citizens lowers AtriCure stock price target on valuation adjustment By Investing.com - Investing.com South Africa
AtriCure (ATRC): BTIG Reiterates Buy Rating and $54 PT | ATRC St - GuruFocus
AtriCure posts Q4 beats on 13% growth, analysts label it 'undervalued' despite rising competition - MassDevice
Citizens lowers AtriCure stock price target on valuation adjustment - Investing.com
Why AtriCure (ATRC) Is Down 12.9% After Issuing 2026 Profitability Guidance And Revenue Outlook - simplywall.st
AtriCure Inc (ATRC) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
AtriCure reports surprise Q4 profit on strong worldwide revenue growth - AlphaStreet News
Here's What Key Metrics Tell Us About AtriCure (ATRC) Q4 Earnings - sharewise.com
AtriCure Q4 Earnings Call Highlights - MarketBeat
AtriCure (ATRC) Q4 2025 Earnings Call Transcript - The Globe and Mail
AtriCure Inc (NASDAQ:ATRC) Stock Surges on Q4 2025 Earnings Beat and Profitability Milestone - ChartMill
ATRC Projects FY26 Revenue Between $600M and $610M - GuruFocus
AtriCure (ATRC) Tops Q4 Earnings and Revenue Estimates - Yahoo Finance
AtriCure: Q4 Earnings Snapshot - kens5.com
AtriCure: Fourth Quarter Earnings Overview - Bitget
AtriCure (NASDAQ:ATRC) Announces Earnings Results, Beats Estimates By $0.10 EPS - MarketBeat
AtriCure shares surge as company beats Q4 expectations, issues strong guidance - Investing.com India
Earnings Flash (ATRC) AtriCure, Inc. Reports Q4 Revenue $140.5M, vs. FactSet Est of $139.7M - marketscreener.com
AtriCure Reports Fourth Quarter and Full Year 2025 Financial Results - TradingView
AtriCure Q4 Earnings Summary & Key Takeaways - Benzinga
AtriCure Reports Fourth Quarter 2025 and Full Year 2025 Financial Results - marketscreener.com
AtriCure Q4 2025 Earnings Call Transcript - MarketBeat
Market Outlook: Is AtriCure Inc undervalued by DCF analysisTrade Risk Summary & Weekly High Momentum Picks - baoquankhu1.vn
AtriCure, Inc. (ATRC) Stock Analysis: Analyst Ratings Suggest A 57.56% Upside Potential - DirectorsTalk Interviews
Smart Money: Should value investors consider AtriCure IncMarket Volume Summary & Consistent Profit Trade Alerts - baoquankhu1.vn
AtriCure earnings on deck as analysts split on growth outlook By Investing.com - Investing.com UK
AtriCure earnings on deck as analysts split on growth outlook - Investing.com Nigeria
Insights into AtriCure's Upcoming Earnings - Benzinga
NeoGenomics Announces Launch of New Cancer Assay PanTracer Pro - Finviz
Quarterly Recap: What are the analyst revisions for SMTCIs AtriCure Inc stock a good investment in YEAR2025 Trading Recap & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
Can JPMorgan’s Downgrade Reshape AtriCure’s (ATRC) Competitive Moat In Cardiac Surgery Devices? - Yahoo Finance
Atricure Inc (ATRC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.36%
0.05%
자본화:
|
볼륨(24시간):